메뉴 건너뛰기




Volumn 160, Issue 3, 2012, Pages 418-430

Drug nanocrystals: In vivo performances

Author keywords

Bioavailability; Drug nanocrystals; Pharmacodynamics; Pharmacokinetics; Poorly soluble drugs; Targeting drug delivery

Indexed keywords

BIOAVAILABILITY; CRYSTALLINE STRUCTURE; IN-VITRO; IN-VIVO; PHYSICAL AND CHEMICAL PROPERTIES; POORLY SOLUBLE DRUGS;

EID: 84861960852     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2012.03.013     Document Type: Review
Times cited : (307)

References (155)
  • 1
    • 0036742053 scopus 로고    scopus 로고
    • Poor aqueous solubility - An industry wide problem in drug discovery
    • C. Lipinski, Poor aqueous solubility - an industry wide problem in drug discovery, Am. Pharm. Rev. 5 (2002) 82-85.
    • (2002) Am. Pharm. Rev. , vol.5 , pp. 82-85
    • Lipinski, C.1
  • 2
    • 75549088273 scopus 로고    scopus 로고
    • Nanoparticles: A personal experience for formulating poorly water soluble drugs
    • E.R. Cooper, Nanoparticles: a personal experience for formulating poorly water soluble drugs, J. Control. Release 141 (2010) 300-302.
    • (2010) J. Control. Release , vol.141 , pp. 300-302
    • Cooper, E.R.1
  • 3
    • 28444461830 scopus 로고    scopus 로고
    • Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation
    • DOI 10.1016/j.ejpb.2005.05.009, PII S0939641105001797
    • C.M. Keck, R.H. Müller, Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation, Eur. J. Pharm. Biopharm. 62 (2006) 3-16. (Pubitemid 41736019)
    • (2006) European Journal of Pharmaceutics and Biopharmaceutics , vol.62 , Issue.1 , pp. 3-16
    • Keck, C.M.1    Muller, R.H.2
  • 4
    • 4544383493 scopus 로고    scopus 로고
    • Nanosuspensions in drug delivery
    • DOI 10.1038/nrd1494
    • B.E. Rabinow, Nanosuspensions in drug delivery, Nat. Rev. Drug Discov. 3 (2004) 785-796. (Pubitemid 39242830)
    • (2004) Nature Reviews Drug Discovery , vol.3 , Issue.9 , pp. 785-796
    • Rabinow, B.E.1
  • 5
    • 42549152846 scopus 로고    scopus 로고
    • Drug nanocrystals for the formulation of poorly soluble drugs and its application as a potential drug delivery system
    • L. Gao, D. Zhang, M. Chen, Drug nanocrystals for the formulation of poorly soluble drugs and its application as a potential drug delivery system, J. Nanopart. Res. 10 (2008) 845-862.
    • (2008) J. Nanopart. Res. , vol.10 , pp. 845-862
    • Gao, L.1    Zhang, D.2    Chen, M.3
  • 6
    • 0029080002 scopus 로고
    • Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs
    • G.G. Liversidge, K.C. Cundy, Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs, Int. J. Pharm. 125 (1995) 91-97.
    • (1995) Int. J. Pharm. , vol.125 , pp. 91-97
    • Liversidge, G.G.1    Cundy, K.C.2
  • 7
    • 0033965872 scopus 로고    scopus 로고
    • Preparation of a clofazimine nanosuspension for intravenous use and evaluation of its therapeutic efficacy in murine Mycobacterium avium infection
    • K. Peters, S. Leitzke, J. Diederichs, K. Borner, H. Hahn, R.H. Müller, S. Ehlers, Preparation of a clofazimine nanosuspension for intravenous use and evaluation of its therapeutic efficacy in murine Mycobacterium avium infection, J. Antimicrob. Chemother. 45 (2000) 77-83. (Pubitemid 30060237)
    • (2000) Journal of Antimicrobial Chemotherapy , vol.45 , Issue.1 , pp. 77-83
    • Peters, K.1    Leitzke, S.2    Diederichs, J.E.3    Borner, K.4    Hahn, H.5    Muller, R.H.6    Ehlers, S.7
  • 9
    • 0036176196 scopus 로고    scopus 로고
    • Production and characterization of a budesonide nanosuspension for pulmonary administration
    • DOI 10.1023/A:1014276917363
    • C. Jacobs, R.H. Müller, Production and characterization of a budesonide nanosuspension for pulmonary administration, Pharm. Res. 19 (2002) 189-194. (Pubitemid 34165405)
    • (2002) Pharmaceutical Research , vol.19 , Issue.2 , pp. 189-194
    • Jacobs, C.1    Muller, R.H.2
  • 10
    • 0035937599 scopus 로고    scopus 로고
    • Nanosuspensions as particulate drug formulations in therapy: Rationale for development and what we can expect for the future
    • DOI 10.1016/S0169-409X(00)00118-6, PII S0169409X00001186
    • R.H. Müller, C. Jacobs, O. Kayser, Nanosuspensions as particulate drug formulations in therapy: rationale for development and what we can expect for the future, Adv. Drug Deliv. Rev. 47 (2001) 3-19. (Pubitemid 32209229)
    • (2001) Advanced Drug Delivery Reviews , vol.47 , Issue.1 , pp. 3-19
    • Muller, R.H.1    Jacobs, C.2    Kayser, O.3
  • 11
    • 53949092998 scopus 로고    scopus 로고
    • Top-down production of drug nanocrystals: Nanosuspension stabilization, miniaturization and transformation into solid products
    • B. Van Eerdenbrugh, G. Van den Mooter, P. Augustijns, Top-down production of drug nanocrystals: nanosuspension stabilization, miniaturization and transformation into solid products, Int. J. Pharm. 364 (2008) 64-75.
    • (2008) Int. J. Pharm. , vol.364 , pp. 64-75
    • Van Eerdenbrugh, B.1    Van Den Mooter, G.2    Augustijns, P.3
  • 13
    • 1842559836 scopus 로고    scopus 로고
    • Nanoparticle Engineering Processes for Enhancing the Dissolution Rates of Poorly Water Soluble Drugs
    • DOI 10.1081/DDC-120030422
    • J. Hu, K.P. Johnston, R.O. Williams, Nanoparticle engineering processes for enhancing the dissolution rates of poorly water soluble drugs, Drug Dev. Ind. Pharm. 30 (2004) 233-245. (Pubitemid 38451748)
    • (2004) Drug Development and Industrial Pharmacy , vol.30 , Issue.3 , pp. 233-245
    • Hu, J.1    Johnston, K.P.2    Williams III, R.O.3
  • 14
    • 69749103682 scopus 로고    scopus 로고
    • Nanocrystal technology, drug delivery and clinical applications
    • J.A.H. Junghanns, R.H. Müller, Nanocrystal technology, drug delivery and clinical applications, Int. J. Nanomedicine 3 (2008) 295-310.
    • (2008) Int. J. Nanomedicine , vol.3 , pp. 295-310
    • Junghanns, J.A.H.1    Müller, R.H.2
  • 15
    • 0025304474 scopus 로고
    • Mechanisms of creatine kinase release from isolated rat skeletal muscles damaged by propylene glycol and ethanol
    • DOI 10.1002/jps.2600790506
    • G.A. Brazeau, H.L. Fung, Mechanisms of creatine kinase release from isolated rat skeletal muscles damaged by propylene glycol and ethanol, J. Pharm. Sci. 79 (1990) 393-397. (Pubitemid 20152168)
    • (1990) Journal of Pharmaceutical Sciences , vol.79 , Issue.5 , pp. 393-397
    • Brazeau, G.A.1    Fung, H.-L.2
  • 16
    • 0016980286 scopus 로고
    • Polyethylene glycol as a solvent for diazepam: Bioavailability and clinical effects after intramuscular administration, comparison of oral, intramuscular and rectal administration, and precipitation from intravenous solutions
    • K. Korttila, A. Sothman, P. Andersson, Polyethylene glycol as a solvent for diazepam: bioavailability and clinical effects after intramuscular administration, comparison of oral, intramuscular and rectal administration, and precipitation from intravenous solutions, Acta Pharmacol. Toxicol. (Copenh) 39 (1976) 104-117.
    • (1976) Acta Pharmacol. Toxicol. (Copenh) , vol.39 , pp. 104-117
    • Korttila, K.1    Sothman, A.2    Andersson, P.3
  • 17
    • 0018749130 scopus 로고
    • Experiments on the toxic, sedative and muscle relaxant potency of various drug solvents in mice
    • DOI 10.1016/0163-7258(79)90119-0
    • R. Budden, U.G. Kuhl, J. Bahlsen, Experiments on toxic, sedative and muscle relaxant potency of various drug solvents in mice, Pharmacol. Ther. 5 (1979) 467-474. (Pubitemid 9227944)
    • (1979) Pharmacology and Therapeutics , vol.5 , Issue.1-3 , pp. 467-474
    • Budden, R.1    Kuehl, U.G.2    Bahlsen, J.3
  • 20
    • 34548049483 scopus 로고    scopus 로고
    • Nanosizing - Oral formulation development and biopharmaceutical evaluation
    • DOI 10.1016/j.addr.2007.05.003, PII S0169409X0700083X
    • F. Kesisoglou, S. Panmai, Y. Wu, Nanosizing - oral formulation development and biopharmaceutical evaluation, Adv. Drug Deliv. Rev. 59 (2007) 631-644. (Pubitemid 47285408)
    • (2007) Advanced Drug Delivery Reviews , vol.59 , Issue.7 , pp. 631-644
    • Kesisoglou, F.1    Panmai, S.2    Wu, Y.3
  • 21
    • 59949091205 scopus 로고    scopus 로고
    • Diclofenac-loaded biopolymeric nanosuspensions for ophthalmic application
    • S.M. Agnihotri, P.R. Vavia, Diclofenac-loaded biopolymeric nanosuspensions for ophthalmic application, Nanomedicine 5 (2009) 90-95.
    • (2009) Nanomedicine , vol.5 , pp. 90-95
    • Agnihotri, S.M.1    Vavia, P.R.2
  • 22
    • 0028824401 scopus 로고
    • Drug particle size reduction for decreasing gastric irritancy and enhancing absorption of naproxen in rats
    • G.G. Liversidge, P. Conzentino, Drug particle size reduction for decreasing gastric irritancy and enhancing absorption of naproxen in rats, Int. J. Pharm. 125 (1995) 309-313.
    • (1995) Int. J. Pharm. , vol.125 , pp. 309-313
    • Liversidge, G.G.1    Conzentino, P.2
  • 23
    • 79957861493 scopus 로고    scopus 로고
    • Nanosizing for oral and parenteral drug delivery: A perspective on formulating poorly-water soluble compounds using wet media milling technology
    • E. Merisko-Liversidge, G.G. Liversidge, Nanosizing for oral and parenteral drug delivery: a perspective on formulating poorly-water soluble compounds using wet media milling technology, Adv. Drug Deliv. Rev. 30 (2011) 427-440.
    • (2011) Adv. Drug Deliv. Rev. , vol.30 , pp. 427-440
    • Merisko-Liversidge, E.1    Liversidge, G.G.2
  • 24
    • 0033178415 scopus 로고    scopus 로고
    • Lab-scale production unit design for nanosuspensions of sparingly soluble cytotoxic drugs
    • B.H.L. Böhm, R.H. Müller, Lab-scale production unit design for nanosuspensions of sparingly soluble cytotoxic drugs, Pharm. Sci. Technol. Today 2 (1999) 336-339.
    • (1999) Pharm. Sci. Technol. Today , vol.2 , pp. 336-339
    • Böhm, B.H.L.1    Müller, R.H.2
  • 25
    • 0742287242 scopus 로고    scopus 로고
    • Comparative safety of amphotericin B lipid complex and amphotericin B deoxycholate as aerosolized antifungal prophylaxis in lung-transplant recipients
    • DOI 10.1097/01.TP.0000101516.08327.A9
    • R.H. Drew, E. Dodds Ashley, D.K. Benjamin Jr., R. Duane Davis, S.M. Palmer, J.R. Perfect, Comparative safety of amphotericin B lipid complex and amphotericin B deoxycholate as aerosolized antifungal prophylaxis in lung-transplant recipients, Transplantation 77 (2004) 232-237. (Pubitemid 38155752)
    • (2004) Transplantation , vol.77 , Issue.2 , pp. 232-237
    • Drew, R.H.1    Ashley, E.D.2    Benjamin Jr., D.K.3    Davis, R.D.4    Palmer, S.M.5    Perfect, J.R.6
  • 26
    • 0029148693 scopus 로고
    • The physiologic effects of inhaled amphotericin B
    • J. Dubois, T. Bartter, J. Gryn, M.R. Pratter, The physiologic effects of inhaled amphotericin B, Chest 108 (1995) 750-753.
    • (1995) Chest , vol.108 , pp. 750-753
    • Dubois, J.1    Bartter, T.2    Gryn, J.3    Pratter, M.R.4
  • 28
    • 0032935231 scopus 로고    scopus 로고
    • Formulation of a protein with propellant HFA 134a for aerosol delivery
    • DOI 10.1016/S0928-0987(98)00015-3, PII S0928098798000153
    • R.O. Williams III, J. Liu, Formulation of a protein with propellant HFA 134a for aerosol delivery, Eur. J. Pharm. Sci. 7 (1999) 137-144. (Pubitemid 29056236)
    • (1999) European Journal of Pharmaceutical Sciences , vol.7 , Issue.2 , pp. 137-144
    • Williams, I.R.O.1    Liu, J.2
  • 29
    • 0026965892 scopus 로고
    • Pharmaceutical evaluation of a new spacer device for delivery of metered-dose inhalers to infants and young children
    • I.C. Ashurst, C.V. Ambrose, D.J. Russell, Pharmaceutical evaluation of a new spacer device for delivery of metered-dose inhalers to infants and young children, J. Aerosol Sci. 23 (1992) 499-502.
    • (1992) J. Aerosol Sci. , vol.23 , pp. 499-502
    • Ashurst, I.C.1    Ambrose, C.V.2    Russell, D.J.3
  • 30
    • 0032950123 scopus 로고    scopus 로고
    • Physical stability of ethyl diatrizoate nanocrystalline suspension in steam sterilization
    • G.C. Na, H.J. Stevens, B. Yuan, N. Rajagopalan, Physical stability of ethyl diatrizoate nanocrystalline suspension in steam sterilization, Pharm. Res. 16 (1999) 569-574. (Pubitemid 29191304)
    • (1999) Pharmaceutical Research , vol.16 , Issue.4 , pp. 569-574
    • Na, G.C.1    Stevens Jr., H.J.2    Yuan, B.O.3    Rajagopalan, N.4
  • 32
    • 41349120910 scopus 로고    scopus 로고
    • Studies on pharmacokinetics and tissue distribution of oridonin nanosuspensions
    • L. Gao, D. Zhang, M. Chen, C. Duan, W. Dai, L. Jia, W. Zhao, Studies on pharmacokinetics and tissue distribution of oridonin nanosuspensions, Int. J. Pharm. 355 (2008) 321-327.
    • (2008) Int. J. Pharm. , vol.355 , pp. 321-327
    • Gao, L.1    Zhang, D.2    Chen, M.3    Duan, C.4    Dai, W.5    Jia, L.6    Zhao, W.7
  • 33
    • 0034996764 scopus 로고    scopus 로고
    • Long circulating and target-specific nanoparticles: Theory to practice
    • S.M. Moghimi, A.C. Hunter, J.C. Murray, Long circulating and target-specific nanoparticles: theory to practice, Pharmacol. Rev. 53 (2001) 283-381.
    • (2001) Pharmacol. Rev. , vol.53 , pp. 283-381
    • Moghimi, S.M.1    Hunter, A.C.2    Murray, J.C.3
  • 34
    • 58249109448 scopus 로고    scopus 로고
    • Formulation and pharmacokinetic evaluation of an asulacrine nanocrystalline suspension for intravenous delivery
    • S. Ganta, J.W. Paxton, B.C. Baguley, S. Garg, Formulation and pharmacokinetic evaluation of an asulacrine nanocrystalline suspension for intravenous delivery, Int. J. Pharm. 367 (2009) 179-186.
    • (2009) Int. J. Pharm. , vol.367 , pp. 179-186
    • Ganta, S.1    Paxton, J.W.2    Baguley, B.C.3    Garg, S.4
  • 36
    • 71049183092 scopus 로고    scopus 로고
    • Particle size reduction for improvement of oral absorption absorption of the poorly soluble drug UG558 in rats during early development
    • K. Sigfridsson, A.J. Lundqvist, M. Strimfors, Particle size reduction for improvement of oral absorption absorption of the poorly soluble drug UG558 in rats during early development, Drug Dev. Ind. Pharm. 35 (2009) 1479-1486.
    • (2009) Drug Dev. Ind. Pharm. , vol.35 , pp. 1479-1486
    • Sigfridsson, K.1    Lundqvist, A.J.2    Strimfors, M.3
  • 37
    • 79952961931 scopus 로고    scopus 로고
    • Folate-targeted drug-delivery systems prepared by nanocomminution
    • S. Kim, J. Lee, Folate-targeted drug-delivery systems prepared by nanocomminution, Drug Dev. Ind. Pharm. 37 (2011) 131-138.
    • (2011) Drug Dev. Ind. Pharm. , vol.37 , pp. 131-138
    • Kim, S.1    Lee, J.2
  • 38
    • 38349162256 scopus 로고    scopus 로고
    • Preparation and characterization of intravenously injectable nimodipine nanosuspension
    • R. Xiong, W. Lu, J. Li, P. Wang, R. Xu, T. Chen, Preparation and characterization of intravenously injectable nimodipine nanosuspension, Int. J. Pharm. 350 (2008) 338-343.
    • (2008) Int. J. Pharm. , vol.350 , pp. 338-343
    • Xiong, R.1    Lu, W.2    Li, J.3    Wang, P.4    Xu, R.5    Chen, T.6
  • 39
    • 78650778104 scopus 로고    scopus 로고
    • Preparation and characterization of intravenously injectable curcumin nanosuspension
    • Y. Gao, Z. Li, M. Sun, C. Guo, A. Yu, Y. Xi, J. Cui, H. Lou, G. Zhai, Preparation and characterization of intravenously injectable curcumin nanosuspension, Drug Deliv. 18 (2011) 131-142.
    • (2011) Drug Deliv. , vol.18 , pp. 131-142
    • Gao, Y.1    Li, Z.2    Sun, M.3    Guo, C.4    Yu, A.5    Xi, Y.6    Cui, J.7    Lou, H.8    Zhai, G.9
  • 40
    • 0342897023 scopus 로고    scopus 로고
    • Nanosuspensions for the formulation of poorly soluble drugs. I. Preparation by a size-reduction technique
    • DOI 10.1016/S0378-5173(97)00311-6, PII S0378517397003116
    • R.H. Müller, K. Peters, Nanosuspensions for the formulation of poorly soluble drugs I. Preparation by a size-reduction technique, Int. J. Pharm. 160 (1998) 229-237. (Pubitemid 28083096)
    • (1998) International Journal of Pharmaceutics , vol.160 , Issue.2 , pp. 229-237
    • Muller, R.H.1    Peters, K.2
  • 41
    • 52949128719 scopus 로고    scopus 로고
    • Comparison of nanosuspensions and hydroxypropyl-b-cyclodextrin complex of melarsoprol: Pharmacokinetics and tissue distribution in mice
    • S.B. Zirar, A. Astier, M. Muchow, S. Gibaud, Comparison of nanosuspensions and hydroxypropyl-b-cyclodextrin complex of melarsoprol: pharmacokinetics and tissue distribution in mice, Eur. J. Pharm. Biopharm. 70 (2008) 649-656.
    • (2008) Eur. J. Pharm. Biopharm. , vol.70 , pp. 649-656
    • Zirar, S.B.1    Astier, A.2    Muchow, M.3    Gibaud, S.4
  • 42
    • 33646515151 scopus 로고    scopus 로고
    • A phase I study with oral SU5416 in patients with advanced solid tumors: A drug inducing its clearance
    • M. Salzberg, M. Pless, C. Rochlitz, K. Ambrus, P. Scigalla, R. Herrmann, A phase I study with oral SU5416 in patients with advanced solid tumors: a drug inducing its clearance, Invest. New Drugs 24 (2006) 299-304.
    • (2006) Invest. New Drugs , vol.24 , pp. 299-304
    • Salzberg, M.1    Pless, M.2    Rochlitz, C.3    Ambrus, K.4    Scigalla, P.5    Herrmann, R.6
  • 48
    • 57049157156 scopus 로고    scopus 로고
    • Pharmacokinetics of a novel submicron budesonide dispersion for nebulized delivery in asthma
    • S.B. Shrewsbury, A.P. Bosco, P.S. Uster, Pharmacokinetics of a novel submicron budesonide dispersion for nebulized delivery in asthma, Int. J. Pharm. 365 (2009) 12-17.
    • (2009) Int. J. Pharm. , vol.365 , pp. 12-17
    • Shrewsbury, S.B.1    Bosco, A.P.2    Uster, P.S.3
  • 49
    • 0027403986 scopus 로고
    • Surface modification of i.v. injectable biodegradable nanoparticles with poloxamer polymers and poloxamine 908
    • DOI 10.1016/0378-5173(93)90304-X
    • R.H. Müller, K.H. Wallis, Surface modification of i.v. injectable biodegradable nanoparticles with poloxamer polymers and poloxamine 908, Int. J. Pharm. 89 (1993) 25-31. (Pubitemid 23008588)
    • (1993) International Journal of Pharmaceutics , vol.89 , Issue.1 , pp. 25-31
    • Muller, R.H.1    Wallis, K.H.2
  • 50
    • 0037072566 scopus 로고    scopus 로고
    • Nanoparticles in cancer therapy and diagnosis
    • DOI 10.1016/S0169-409X(02)00044-3, PII S0169409X02000443
    • I. Brigger, C. Dubernet, P. Couvreur, Nanoparticles in cancer therapy and diagnosis, Adv. Drug Deliv. Rev. 54 (2002) 631-651. (Pubitemid 35247520)
    • (2002) Advanced Drug Delivery Reviews , vol.54 , Issue.5 , pp. 631-651
    • Brigger, I.1    Dubernet, C.2    Couvreur, P.3
  • 51
    • 0033805179 scopus 로고    scopus 로고
    • In vitro-in vivo correlations for lipophilic, poorly water-soluble drugs
    • J.B. Dressman, C. Reppas, In vitro-in vivo correlations for lipophilic, poorly water-soluble drugs, Eur. J. Pharm. Sci. 11 (2000) 73-80.
    • (2000) Eur. J. Pharm. Sci. , vol.11 , pp. 73-80
    • Dressman, J.B.1    Reppas, C.2
  • 52
    • 77953683770 scopus 로고    scopus 로고
    • Targeting nanoparticles to cancer
    • M. Wang, M. Thanou, Targeting nanoparticles to cancer, Pharmacol. Res. 62 (2010) 90-99.
    • (2010) Pharmacol. Res. , vol.62 , pp. 90-99
    • Wang, M.1    Thanou, M.2
  • 53
    • 78650679438 scopus 로고    scopus 로고
    • Preparation of a chemically stable quercetin formulation using nanosuspension technology
    • L. Gao, G. Liu, X. Wang, F. Liu, Y. Xu, J. Ma, Preparation of a chemically stable quercetin formulation using nanosuspension technology, Int. J. Pharm. 404 (2011) 231-237.
    • (2011) Int. J. Pharm. , vol.404 , pp. 231-237
    • Gao, L.1    Liu, G.2    Wang, X.3    Liu, F.4    Xu, Y.5    Ma, J.6
  • 55
    • 70350639421 scopus 로고    scopus 로고
    • Preparation of fenofibrate nanosuspension and study of its pharmacokinetic behavior in rats
    • X. Li, L. Gu, Y. Xu, Y. Wang, Preparation of fenofibrate nanosuspension and study of its pharmacokinetic behavior in rats, Drug Dev. Ind. Pharm. 35 (2009) 827-833.
    • (2009) Drug Dev. Ind. Pharm. , vol.35 , pp. 827-833
    • Li, X.1    Gu, L.2    Xu, Y.3    Wang, Y.4
  • 56
    • 34547863131 scopus 로고    scopus 로고
    • Pharmacokinetic evaluation of oral fenofibrate nanosuspensions and SLN in comparison to conventional suspensions of micronized drug
    • DOI 10.1016/j.addr.2007.04.005, PII S0169409X07000397, Lipid Nanoparticles: Recent Advances
    • A. Hanafy, H. Spahn-Langguth, G. Vergnault, P. Grenier, M. Tubic Grozdanis, T. Lenhardt, P. Langguth, Pharmacokinetic evaluation of oral fenofibrate nanosuspensions and SLN in comparison to conventional suspensions of micronized drug, Adv. Drug Deliv. Rev. 59 (2007) 419-426. (Pubitemid 47260709)
    • (2007) Advanced Drug Delivery Reviews , vol.59 , Issue.6 , pp. 419-426
    • Hanafy, A.1    Spahn-Langguth, H.2    Vergnault, G.3    Grenier, P.4    Tubic, G.M.5    Lenhardt, T.6    Langguth, P.7
  • 58
    • 42149190687 scopus 로고    scopus 로고
    • Oral delivery of 1,3-dicyclohexylurea nanosuspension enhances exposure and lowers blood pressure in hypertensive rats
    • DOI 10.1111/j.1742-7843.2008.00213.x
    • S. Ghosh, P. Chiang, J.L. Wahlstrom, H. Fujiwara, J.G. Selbo, S.L. Roberds, Oral delivery of 1,3-dicyclohexylurea nanosuspension enhances exposure and lowers blood pressure in hypertensive rats, Basic Clin. Pharmacol. Toxicol. 102 (2008) 453-458. (Pubitemid 351537788)
    • (2008) Basic and Clinical Pharmacology and Toxicology , vol.102 , Issue.5 , pp. 453-458
    • Ghosh, S.1    Chiang, P.-C.2    Wahlstrom, J.L.3    Fujiwara, H.4    Selbo, J.G.5    Roberds, S.L.6
  • 61
    • 79952922229 scopus 로고    scopus 로고
    • A formulation comparison between micro- And nanosuspensions: The importance of particle size for absorption of a model compound, following repeated oral administration to rats during early development
    • K. Sigfridsson, A. Nordmark, S. Theilig, A. Lindah, A formulation comparison between micro- and nanosuspensions: the importance of particle size for absorption of a model compound, following repeated oral administration to rats during early development, Drug Dev. Ind. Pharm. 37 (2011) 185-192.
    • (2011) Drug Dev. Ind. Pharm. , vol.37 , pp. 185-192
    • Sigfridsson, K.1    Nordmark, A.2    Theilig, S.3    Lindah, A.4
  • 62
    • 33344478634 scopus 로고    scopus 로고
    • Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogs
    • DOI 10.1016/j.jconrel.2005.11.013, PII S0168365905006565
    • J. Jinno, N. Kamada, M. Miyake, K. Yamada, T. Mukai, M. Odomi, H. Toguchi, G.G. Liversidge, K. Higaki, T. Kimura, Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogs, J. Control. Release 111 (2006) 56-64. (Pubitemid 43289995)
    • (2006) Journal of Controlled Release , vol.111 , Issue.1-2 , pp. 56-64
    • Jinno, J.-I.1    Kamada, N.2    Miyake, M.3    Yamada, K.4    Mukai, T.5    Odomi, M.6    Toguchi, H.7    Liversidge, G.G.8    Higaki, K.9    Kimura, T.10
  • 63
    • 20844446627 scopus 로고    scopus 로고
    • The role of biopharmaceutics in the development of a clinical nanoparticle formulation of MK-0869: A Beagle dog model predicts improved bioavailability and diminished food effect on absorption in human
    • DOI 10.1016/j.ijpharm.2004.08.001, PII S0378517304004831
    • Y. Wu, A. Loper, E. Landis, L. Hettrick, L. Novak, K. Lynn, C. Chen, K. Thompson, R. Higgins, U. Batra, S. Shelukar, G. Kwei, D. Storey, The role of biopharmaceutics in the development of a clinical nanoparticle formulation of MK-0869: a beagle dog model predicts improved bioavailability and diminished food effect on absorption in human, Int. J. Pharm. 285 (2004) 135-146. (Pubitemid 39361543)
    • (2004) International Journal of Pharmaceutics , vol.285 , Issue.1-2 , pp. 135-146
    • Wu, Y.1    Loper, A.2    Landis, E.3    Hettrick, L.4    Novak, L.5    Lynn, K.6    Chen, C.7    Thompson, K.8    Higgins, R.9    Batra, U.10    Shelukar, S.11    Kwei, G.12    Storey, D.13
  • 64
    • 33744973517 scopus 로고    scopus 로고
    • Oral bioavailability of cyclosporine: Solid lipid nanoparticles (SLN®) versus drug nanocrystals
    • DOI 10.1016/j.ijpharm.2006.02.045, PII S037851730600192X
    • R.H. Müller, S. Runge, V. Ravelli, W. Mehnert, A.F. Thünemann, E.B. Souto, Oral bioavailability of cyclosporine: solid lipid nanoparticles (SLN®) versus drug nanocrystals, Int. J. Pharm. 317 (2006) 82-89. (Pubitemid 43866342)
    • (2006) International Journal of Pharmaceutics , vol.317 , Issue.1 , pp. 82-89
    • Muller, R.H.1    Runge, S.2    Ravelli, V.3    Mehnert, W.4    Thunemann, A.F.5    Souto, E.B.6
  • 67
    • 17444372009 scopus 로고    scopus 로고
    • Mucoadhesives in the gastrointestinal tract: Revisiting the literature for novel applications
    • DOI 10.1016/j.ejpb.2005.01.007
    • D. Dodou, P. Breedveld, P.A. Wieringa, Mucoadhesives in the gastrointestinal tract: revisiting the literature for novel applications, Eur. J. Pharm. Biopharm. 60 (2005) 1-16. (Pubitemid 40545855)
    • (2005) European Journal of Pharmaceutics and Biopharmaceutics , vol.60 , Issue.1 , pp. 1-16
    • Dodou, D.1    Breedveld, P.2    Wieringa, P.A.3
  • 68
    • 26644454810 scopus 로고    scopus 로고
    • The basics and underlying mechanisms of mucoadhesion
    • DOI 10.1016/j.addr.2005.07.001, PII S0169409X05001390, Mucoadhesive Polymers: Strategies, Achievements and Future Challenges
    • J.D. Smart, The basics and underlying mechanisms of mucoadhesion, Adv. Drug Deliv. Rev. 57 (2005) 1556-1568. (Pubitemid 41443469)
    • (2005) Advanced Drug Delivery Reviews , vol.57 , Issue.11 , pp. 1556-1568
    • Smart, J.D.1
  • 69
    • 0035910888 scopus 로고    scopus 로고
    • A new approach for targeting to Cryptosporidium parvum using mucoadhesive nanosuspensions: Research and applications
    • DOI 10.1016/S0378-5173(00)00640-2, PII S0378517300006402
    • O. Kayser, A newapproach for targeting to Cryptosporidiumparvum usingmucoadhesive nanosuspensions: research and applications, Int. J. Pharm. 214 (2001) 83-85. (Pubitemid 32244083)
    • (2001) International Journal of Pharmaceutics , vol.214 , Issue.1-2 , pp. 83-85
    • Kayser, O.1
  • 70
    • 33751253462 scopus 로고    scopus 로고
    • Nanoparticles as potential oral delivery systems of proteins and vaccines: A mechanistic approach
    • DOI 10.1016/j.jconrel.2006.08.013, PII S0168365906004020
    • A. des Rieux, V. Fievez, M. Garinot, Y.J. Schneider, V. Préat, Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach, J. Control. Release 116 (2006) 1-27. (Pubitemid 44792295)
    • (2006) Journal of Controlled Release , vol.116 , Issue.1 , pp. 1-27
    • Des, R.A.1    Fievez, V.2    Garinot, M.3    Schneider, Y.-J.4    Preat, V.5
  • 71
    • 33748885473 scopus 로고    scopus 로고
    • Low molecular weight heparin nanoparticles: Mucoadhesion and behaviour in Caco-2 cells
    • DOI 10.1088/0957-4484/17/15/009, PII S0957448406226916, 009
    • A. Lamprecht, P. Koenig, N. Ubrich, P. Maincent, D. Neumann, Low molecular weight heparin nanoparticles: mucoadhesion and behaviour in Caco-2 cells, Nanotechnology 17 (2006) 3673-3680. (Pubitemid 44424393)
    • (2006) Nanotechnology , vol.17 , Issue.15 , pp. 3673-3680
    • Lamprecht, A.1    Koenig, P.2    Ubrich, N.3    Maincent, P.4    Neumann, D.5
  • 72
    • 0032402219 scopus 로고    scopus 로고
    • Evaluation of nano- and microparticle uptake by the gastrointestinal tract
    • DOI 10.1016/S0169-409X(98)00041-6, PII S0169409X98000416
    • F. Delie, Evaluation of nano- and microparticle uptake by the gastrointestinal tract, Adv. Drug Deliv. Rev. 34 (1998) 221-233. (Pubitemid 28535113)
    • (1998) Advanced Drug Delivery Reviews , vol.34 , Issue.2-3 , pp. 221-233
    • Delie, F.1
  • 74
    • 0030471901 scopus 로고    scopus 로고
    • Gastrointestinal uptake of biodegradable microparticles: Effect of particle size
    • DOI 10.1023/A:1016085108889
    • M.P. Desai, V. Labhasetwar, G.L. Amidon, R.J. Levy Gastrointestinal, Uptake of biodegradable microparticles: effect of particle size, Pharm. Res. 13 (1996) 1838-1845. (Pubitemid 27034116)
    • (1996) Pharmaceutical Research , vol.13 , Issue.12 , pp. 1838-1845
    • Desai, M.P.1    Labhasetwar, V.2    Amidon, G.L.3    Levy, R.J.4
  • 75
    • 33751253462 scopus 로고    scopus 로고
    • Nanoparticles as potential oral delivery systems of proteins and vaccines: A mechanistic approach
    • DOI 10.1016/j.jconrel.2006.08.013, PII S0168365906004020
    • A. des Rieux, V. Fievez, M. Garinot, Y.J. Scheider, V. Preat, Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach, J. Control. Release 116 (2006) 1-27. (Pubitemid 44792295)
    • (2006) Journal of Controlled Release , vol.116 , Issue.1 , pp. 1-27
    • Des, R.A.1    Fievez, V.2    Garinot, M.3    Schneider, Y.-J.4    Preat, V.5
  • 76
    • 0032714228 scopus 로고    scopus 로고
    • Inhibition of P-glycoprotein by D-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS)
    • DOI 10.1023/A:1015000503629
    • J.M. Dintaman, J.A. Silverman, Inhibition of P-glycoprotein by D-alphatocopheryl polyethylene glycol 1000 succinate (TPGS), Pharm. Res. 16 (1999) 1550-1556. (Pubitemid 29510551)
    • (1999) Pharmaceutical Research , vol.16 , Issue.10 , pp. 1550-1556
    • Dintaman, J.M.1    Silverman, J.A.2
  • 78
    • 42649107490 scopus 로고    scopus 로고
    • Effect of pluronic F68 block copolymer on P-glycoprotein transport and CYP3A4 metabolism
    • J. Huang, L. Si, L. Jiang, Z. Fan, J. Qiu, G. Li, Effect of pluronic F68 block copolymer on P-glycoprotein transport and CYP3A4 metabolism, Int. J. Pharm. 356 (2008) 351-353.
    • (2008) Int. J. Pharm. , vol.356 , pp. 351-353
    • Huang, J.1    Si, L.2    Jiang, L.3    Fan, Z.4    Qiu, J.5    Li, G.6
  • 80
    • 0033496577 scopus 로고    scopus 로고
    • Relative bioavailability and effects of a high fat meal on single dose cilostazol pharmacokinetics
    • S.L. Bramer,W.P. Forbes, Relative bioavailability and effects of a high fatmeal on single dose cilostazol pharmacokinetics, Clin. Pharmacokinet. 37 (Suppl. 2) (1999) 13-23. (Pubitemid 30171183)
    • (1999) Clinical Pharmacokinetics , vol.37 , Issue.SUPPL. 2 , pp. 13-23
    • Bramer, S.L.1    Forbes, W.P.2
  • 82
    • 51649091116 scopus 로고    scopus 로고
    • Conversion of nanosuspensions into dry powders by spray drying: A case study
    • M.V. Chaubal, C. Popescu, Conversion of nanosuspensions into dry powders by spray drying: a case study, Pharm. Res. 25 (2008) 2302-2308.
    • (2008) Pharm. Res. , vol.25 , pp. 2302-2308
    • Chaubal, M.V.1    Popescu, C.2
  • 84
    • 79958005215 scopus 로고    scopus 로고
    • Potent dried drug nanosuspensions for oral bioavailability enhancement of poorly soluble drugs with pH-dependent solubility
    • D. Mou, H. Chen, J. Wan, H. Xu, X. Yang, Potent dried drug nanosuspensions for oral bioavailability enhancement of poorly soluble drugs with pH-dependent solubility, Int. J. Pharm. 413 (2011) 237-244.
    • (2011) Int. J. Pharm. , vol.413 , pp. 237-244
    • Mou, D.1    Chen, H.2    Wan, J.3    Xu, H.4    Yang, X.5
  • 85
    • 38749119045 scopus 로고    scopus 로고
    • Effect of arginine hydrochloride and hydroxypropyl cellulose as stabilizers on the physical stability of high drug loading nanosuspensions of a poorly soluble compound
    • DOI 10.1016/j.ijpharm.2007.09.029, PII S0378517307008204
    • A. Ain-Ai, P.K. Gupta, Effect of arginine hydrochloride and hydroxypropyl cellulose as stabilizers on the physical stability of high drug loading nanosuspensions of a poorly soluble compound, Int. J. Pharm. 351 (2008) 282-288. (Pubitemid 351186858)
    • (2008) International Journal of Pharmaceutics , vol.351 , Issue.1-2 , pp. 282-288
    • Ain-Ai, A.1    Gupta, P.K.2
  • 86
    • 33745617678 scopus 로고    scopus 로고
    • Surface functionalized alumina nanoparticle filled polymeric nanocomposites with enhanced mechanical properties
    • DOI 10.1039/b603020c
    • Z. Guo, T. Pereira, O. Choi, Y. Wang, H.T. Hahn, Surface functionalized alumina nanoparticle filled polymeric nanocomposites with enhanced mechanical properties, J. Mater. Chem. 16 (2006) 2800-2808. (Pubitemid 43993797)
    • (2006) Journal of Materials Chemistry , vol.16 , Issue.27 , pp. 2800-2808
    • Guo, Z.1    Pereira, T.2    Choi, O.3    Wang, Y.4    Hahn, H.T.5
  • 87
    • 60049090585 scopus 로고    scopus 로고
    • Design of biodegradable nanoparticles for oral delivery of doxorubicin: In vivo pharmacokinetics and toxicity studies in rats
    • D.R. Kalaria, G. Sharma, V. Beniwal, M.N. Ravi Kumar, Design of biodegradable nanoparticles for oral delivery of doxorubicin: in vivo pharmacokinetics and toxicity studies in rats, Pharm. Res. 26 (2009) 492-501.
    • (2009) Pharm. Res. , vol.26 , pp. 492-501
    • Kalaria, D.R.1    Sharma, G.2    Beniwal, V.3    Ravi Kumar, M.N.4
  • 88
    • 5344234787 scopus 로고    scopus 로고
    • The role of solid nanoparticle technology in the parenteral delivery of poorly water-soluble drugs
    • DOI 10.1016/j.ijpharm.2004.07.019, PII S0378517304004582
    • J.E. Kipp, The role of solid nanoparticle technology in parenteral delivery of poorly water soluble drugs, Int. J. Pharm. 284 (2004) 109-122. (Pubitemid 39349144)
    • (2004) International Journal of Pharmaceutics , vol.284 , Issue.1-2 , pp. 109-122
    • Kipp, J.E.1
  • 89
    • 78650531221 scopus 로고    scopus 로고
    • SDS-coated atovaquone nanosuspensions show improved therapeutic efficacy against experimental acquired and reactivated toxoplasmosis by improving passage of gastrointestinal and blood-brain barriers
    • H.M. Shubar, S. Lachenmaier, M.M. Heimesaat, U. Lohman, R. Mauludin, R.H. Müller, R. Fitzner, K. Borner, O. Liesenfeld, SDS-coated atovaquone nanosuspensions show improved therapeutic efficacy against experimental acquired and reactivated toxoplasmosis by improving passage of gastrointestinal and blood-brain barriers, J. Drug Target. 19 (2011) 114-124.
    • (2011) J. Drug Target. , vol.19 , pp. 114-124
    • Shubar, H.M.1    Lachenmaier, S.2    Heimesaat, M.M.3    Lohman, U.4    Mauludin, R.5    Müller, R.H.6    Fitzner, R.7    Borner, K.8    Liesenfeld, O.9
  • 90
    • 78649648146 scopus 로고    scopus 로고
    • Pharmaceutical nanocrystals by nanomilling: Critical process parameters, particle fracturing and stabilization method
    • L. Peltonen, J. Hirvonen, Pharmaceutical nanocrystals by nanomilling: critical process parameters, particle fracturing and stabilization method, J. Pharm. Pharmacol. 62 (2010) 1569-1579.
    • (2010) J. Pharm. Pharmacol. , vol.62 , pp. 1569-1579
    • Peltonen, L.1    Hirvonen, J.2
  • 91
    • 67349098845 scopus 로고    scopus 로고
    • Diclofenac nanosuspensions: Influence of preparation procedure and crystal form on drug dissolution behavior
    • F. Lai, C. Sinico, G. Ennas, F. Marongiu, G. Marongiu, A.M. Fadda, Diclofenac nanosuspensions: influence of preparation procedure and crystal form on drug dissolution behavior, Int. J. Pharm. 373 (2009) 124-132.
    • (2009) Int. J. Pharm. , vol.373 , pp. 124-132
    • Lai, F.1    Sinico, C.2    Ennas, G.3    Marongiu, F.4    Marongiu, G.5    Fadda, A.M.6
  • 92
    • 0033805179 scopus 로고    scopus 로고
    • In vitro-in vivo correlations for lipophilic, poorly water-soluble drugs
    • J.B. Dressman, C. Reppas, In vitro-in vivo correlations for lipophilic, poorly water-soluble drugs, Eur. J. Pharm. Sci. 11 (Suppl. 2) (2000) S73-S80.
    • (2000) Eur. J. Pharm. Sci. , vol.11 , Issue.SUPPL. 2
    • Dressman, J.B.1    Reppas, C.2
  • 93
    • 4544275025 scopus 로고    scopus 로고
    • Challenges and solutions for the delivery of biotech drugs - A review of drug nanocrystal technology and lipid nanoparticles
    • DOI 10.1016/j.jbiotec.2004.06.007, PII S0168165604003128
    • R.H. Muller, C.M. Keck, Challenges and solutions for the delivery of biotech drugs - a review of drug nanocrystal technology and lipid nanoparticles, J. Biotechnol. 113 (2004) 151-170. (Pubitemid 39237077)
    • (2004) Journal of Biotechnology , vol.113 , Issue.1-3 , pp. 151-170
    • Muller, R.H.1    Keck, C.M.2
  • 94
    • 34547259640 scopus 로고    scopus 로고
    • Pharmacokinetic evaluation of a 1,3-dicyclohexylurea nanosuspension formulation to support early efficacy assessment
    • DOI 10.1007/s11671-007-9063-7
    • J.L. Wahlstrom, P. Chiang, S. Ghosh, C.J. Warren, S.P. Wene, L.A. Albin, M.E. Smith, S.L. Roberds, Pharmacokinetic evaluation of a 1,3-dicyclohexylurea nanosuspension formulation to support early efficacy assessment, Nanoscale Res. Lett. 2 (2007) 291-296. (Pubitemid 47139334)
    • (2007) Nanoscale Research Letters , vol.2 , Issue.6 , pp. 291-296
    • Wahlstrom, J.L.1    Chiang, P.-C.2    Ghosh, S.3    Warren, C.J.4    Wene, S.P.5    Albin, L.A.6    Smith, M.E.7    Roberds, S.L.8
  • 95
    • 77956398535 scopus 로고    scopus 로고
    • Preparation, characterization, pharmacokinetics, and tissue distribution of curcumin nanosuspension with TPGS as stabilizer
    • Y. Gao, Z. Li,M. Sun,H. Li, C.Guo, J. Cui, A. Li, F. Cao, Y. Xi, H. Lou, G. Zhai, Preparation, characterization, pharmacokinetics, and tissue distribution of curcumin nanosuspension with TPGS as stabilizer, Drug Dev. Ind. Pharm. 36 (2010) 1225-1234.
    • (2010) Drug Dev. Ind. Pharm. , vol.36 , pp. 1225-1234
    • Gao, Y.1    Li, Z.2    Sun, M.3    Li, H.4    Guo, C.5    Cui, J.6    Li, A.7    Cao, F.8    Xi, Y.9    Lou, H.10    Zhai, G.11
  • 96
    • 0006014154 scopus 로고
    • Tissue distribution and plasma clearance of a novel microcrystalline- coated flurbiprofen formulation
    • M. Clement, W. Pugh, I. Parikh, Tissue distribution and plasma clearance of a novel microcrystalline-coated flurbiprofen formulation, Pharmacologist 34 (1992) 204-211.
    • (1992) Pharmacologist , vol.34 , pp. 204-211
    • Clement, M.1    Pugh, W.2    Parikh, I.3
  • 97
    • 67349084376 scopus 로고    scopus 로고
    • Polymeric nanoparticulate system: A potential approach for ocular drug delivery
    • R.C. Nagarwal, S. Kant, P.N. Singh, P. Maiti, J.K. Pandit, Polymeric nanoparticulate system: a potential approach for ocular drug delivery, J. Control. Release 136 (2009) 2-13.
    • (2009) J. Control. Release , vol.136 , pp. 2-13
    • Nagarwal, R.C.1    Kant, S.2    Singh, P.N.3    Maiti, P.4    Pandit, J.K.5
  • 98
    • 77949917853 scopus 로고    scopus 로고
    • Sparfloxacin loaded PLGA nanoparticles for sustained ocular drug delivery
    • H. Gupta, M. Aqil, R.K. Khar, A. Ali, A. Bhatnagar, G. Mittal, Sparfloxacin loaded PLGA nanoparticles for sustained ocular drug delivery, Nanomedicine 6 (2010) 324-333.
    • (2010) Nanomedicine , vol.6 , pp. 324-333
    • Gupta, H.1    Aqil, M.2    Khar, R.K.3    Ali, A.4    Bhatnagar, A.5    Mittal, G.6
  • 99
    • 78651356705 scopus 로고    scopus 로고
    • Hydrocortisone nanosuspensions for ophthalmic delivery: A comparative study between microfluidic nanoprecipitation and media milling
    • H.S. Ali, P. York, A.M. Ali, N. Blagden, Hydrocortisone nanosuspensions for ophthalmic delivery: a comparative study between microfluidic nanoprecipitation and media milling, J. Control. Release 149 (2011) 175-181.
    • (2011) J. Control. Release , vol.149 , pp. 175-181
    • Ali, H.S.1    York, P.2    Ali, A.M.3    Blagden, N.4
  • 101
    • 13844297094 scopus 로고    scopus 로고
    • The impact of nanobiotechnology on the development of new drug delivery systems
    • O. Kayser, A. Lemke, N. Hernández-Trejo, The impact of nanobiotechnology on the development of newdrug delivery systems, Curr. Pharm. Biotechnol. 6 (2005) 3-5. (Pubitemid 40246748)
    • (2005) Current Pharmaceutical Biotechnology , vol.6 , Issue.1 , pp. 3-5
    • Kayser, O.1    Lemke, A.2    Hernandez-Trejo, N.3
  • 102
    • 0035999781 scopus 로고    scopus 로고
    • Flurbiprofen-loaded acrylate polymer nanosuspensions for ophthalmic application
    • DOI 10.1016/S0142-9612(02)00080-7, PII S0142961202000807
    • R. Pignatello, C. Bucolo, G. Spedalieri, A. Maltese, G. Puglisi, Flurbiprofen-loaded acrylate polymer nanosuspensions for ophthalmic application, Biomaterials 23 (2002) 3247-3255. (Pubitemid 34522137)
    • (2002) Biomaterials , vol.23 , Issue.15 , pp. 3247-3255
    • Pignatello, R.1    Bucolo, C.2    Spedalieri, G.3    Maltese, A.4    Puglisi, G.5
  • 103
    • 77957998482 scopus 로고    scopus 로고
    • Nanoparticles in drug delivery: Potential green nanobiomedicine applications
    • R. Ravichandran, Nanoparticles in drug delivery: potential green nanobiomedicine applications, Int. J. Green Nanotechnol. Biomed. 1 (2009) B108-B130.
    • (2009) Int. J. Green Nanotechnol. Biomed. , vol.1
    • Ravichandran, R.1
  • 104
    • 77955052417 scopus 로고    scopus 로고
    • Miconazole nanosuspensions: Influence of formulation variables on particle size reduction and physical stability
    • A.M. Cerdeira, M. Mazzotti, B. Gander, Miconazole nanosuspensions: influence of formulation variables on particle size reduction and physical stability, Int. J. Pharm. 396 (2010) 210-218.
    • (2010) Int. J. Pharm. , vol.396 , pp. 210-218
    • Cerdeira, A.M.1    Mazzotti, M.2    Gander, B.3
  • 105
    • 34447254990 scopus 로고    scopus 로고
    • Nanosuspension as an ophthalmic delivery system for certain glucocorticoid drugs
    • DOI 10.1016/j.ijpharm.2007.03.011, PII S037851730700244X
    • M.A. Kassem, A.A. Abdel Rahman, M.M. Ghorab, M.B. Ahmed, R.M. Khalil, Nanosuspension as an ophthalmic delivery system for certain glucocorticoid drugs, Int. J. Pharm. 340 (2007) 126-133. (Pubitemid 47043351)
    • (2007) International Journal of Pharmaceutics , vol.340 , Issue.1-2 , pp. 126-133
    • Kassem, M.A.1    Abdel, R.A.A.2    Ghorab, M.M.3    Ahmed, M.B.4    Khalil, R.M.5
  • 106
    • 59949091288 scopus 로고    scopus 로고
    • Evaluation of aerosol delivery of nanosuspension for pre-clinical pulmonary drug delivery
    • P. Chiang, J.W. Alsup, Y. Lai, Y. Hu, B.R. Heyde, D. Tung, Evaluation of aerosol delivery of nanosuspension for pre-clinical pulmonary drug delivery, Nanoscale Res. Lett. 4 (2009) 254-261.
    • (2009) Nanoscale Res. Lett. , vol.4 , pp. 254-261
    • Chiang, P.1    Alsup, J.W.2    Lai, Y.3    Hu, Y.4    Heyde, B.R.5    Tung, D.6
  • 108
    • 79957692320 scopus 로고    scopus 로고
    • Formation, characterization, and fate of inhaled drug nanoparticles
    • J. Zhang, L. Wu, H. Chan, W. Watanabe, Formation, characterization, and fate of inhaled drug nanoparticles, Adv. Drug Deliv. Rev. 63 (2011) 441-455.
    • (2011) Adv. Drug Deliv. Rev. , vol.63 , pp. 441-455
    • Zhang, J.1    Wu, L.2    Chan, H.3    Watanabe, W.4
  • 110
    • 0344513087 scopus 로고    scopus 로고
    • Pulmonary drug delivery. Part I: Physiological factors affecting therapeutic effectiveness of aerosolized medications
    • DOI 10.1046/j.1365-2125.2003.01892.x
    • N.R. Labiris, M.B. Dolovich, Pulmonary drug delivery. Part I: physiological factors affecting therapeutic effectiveness of aerosolized medications, Br. J. Clin. Pharmacol. 56 (2003) 588-599. (Pubitemid 37491710)
    • (2003) British Journal of Clinical Pharmacology , vol.56 , Issue.6 , pp. 588-599
    • Labiris, N.R.1    Dolovich, M.B.2
  • 111
    • 33845906339 scopus 로고    scopus 로고
    • Inhaling medicines: Delivering drugs to the body through the lungs
    • DOI 10.1038/nrd2153, PII NRD2153
    • J.S. Patton, P.R. Byron, Inhaling medicines: delivering drugs to the body through the lungs, Nat. Rev. Drug Discov. 6 (2007) 67-74. (Pubitemid 46020287)
    • (2007) Nature Reviews Drug Discovery , vol.6 , Issue.1 , pp. 67-74
    • Patton, J.S.1    Byron, P.R.2
  • 112
  • 114
    • 42649106878 scopus 로고    scopus 로고
    • Nanoparticles: Characteristics, mechanisms of action, and toxicity in pulmonary drug delivery - A review
    • DOI 10.1166/jbn.2007.015
    • S. Gill, R. Lobenberg, T. Ku, S. Azarmi, W. Roa, E.J. Prenner, Nanoparticles: characteristics, mechanisms of action, and toxicity in pulmonary drug delivery-a review, J. Biomed. Nanotechnol. 3 (2007) 107-119. (Pubitemid 351877160)
    • (2007) Journal of Biomedical Nanotechnology , vol.3 , Issue.2 , pp. 107-119
    • Gill, S.1    Lobenberg, R.2    Ku, T.3    Azarmi, S.4    Roa, W.5    Prenner, E.J.6
  • 115
    • 0033495184 scopus 로고    scopus 로고
    • Pharmacodynamics and pharmacokinetics of budesonide: A new nebulized corticosteroid
    • S.J. Szefler, Pharmacodynamics and pharmacokinetics of budesonide: a new nebulized corticosteroid, J. Allergy Clin. Immunol. 104 (1999) S175-S183. (Pubitemid 30246942)
    • (1999) Journal of Allergy and Clinical Immunology , vol.104 , Issue.4 II
    • Szefler, S.J.1
  • 116
    • 77951652999 scopus 로고    scopus 로고
    • Comparison of bioavailability of amorphous versus crystalline itraconazole nanoparticles via pulmonary administration in rats
    • W. Yang, K.P. Johnston, R.O. Williams III, Comparison of bioavailability of amorphous versus crystalline itraconazole nanoparticles via pulmonary administration in rats, Eur. J. Pharm. Biopharm. 75 (2010) 33-41.
    • (2010) Eur. J. Pharm. Biopharm. , vol.75 , pp. 33-41
    • Yang, W.1    Johnston, K.P.2    Williams III, R.O.3
  • 118
    • 0037378033 scopus 로고    scopus 로고
    • In vivo pharmacodynamics of antifungal drugs in treatment of candidiasis
    • DOI 10.1128/AAC.47.4.1179-1186.2003
    • D. Andes, Minireview: in vivo pharmacodynamics of antifungal drugs in treatment of candidiasis, Antimicrob. Agents Chemother. 47 (2003) 1179-1186. (Pubitemid 36368572)
    • (2003) Antimicrobial Agents and Chemotherapy , vol.47 , Issue.4 , pp. 1179-1186
    • Andes, D.1
  • 121
    • 8444227803 scopus 로고    scopus 로고
    • Uptake of folate-conjugated albumin nanoparticles to the SKOV3 cells
    • DOI 10.1016/j.ijpharm.2004.08.015, PII S0378517304004934
    • L. Zhang, S. Hou, S. Mao, D. Wei, X. Song, Y. Lu, Uptake of folate-conjugated albumin nanoparticles to the SKOV3 cells, Int. J. Pharm. 287 (2004) 155-162. (Pubitemid 39487253)
    • (2004) International Journal of Pharmaceutics , vol.287 , Issue.1-2 , pp. 155-162
    • Zhang, L.1    Hou, S.2    Mao, S.3    Wei, D.4    Song, X.5    Lu, Y.6
  • 122
    • 0343882023 scopus 로고    scopus 로고
    • Targeted drug delivery via the folate receptor
    • DOI 10.1016/S0169-409X(99)00062-9, PII S0169409X99000629
    • J. Sudimack, R.J. Lee, Targeted drug delivery via folate receptor, Adv. Drug Deliv. Rev. 41 (2000) 147-162. (Pubitemid 30122955)
    • (2000) Advanced Drug Delivery Reviews , vol.41 , Issue.2 , pp. 147-162
    • Sudimack, J.1    Lee, R.J.2
  • 124
    • 79957794004 scopus 로고    scopus 로고
    • Cancer cell invasion: Treatment and monitoring opportunities in nanomedicine
    • O. Veiseh, F.M. Kievit, R.G. Ellenbogen, M. Zhang, Cancer cell invasion: treatment and monitoring opportunities in nanomedicine, Adv. Drug Deliv. Rev. 63 (2011) 582-596.
    • (2011) Adv. Drug Deliv. Rev. , vol.63 , pp. 582-596
    • Veiseh, O.1    Kievit, F.M.2    Ellenbogen, R.G.3    Zhang, M.4
  • 125
    • 0030853702 scopus 로고    scopus 로고
    • Influence of the type of surfactant on the analgesic effects induced by the peptide dalargin after its delivery across the blood-brain barrier using surfactant-coated nanoparticles
    • DOI 10.1016/S0168-3659(97)00061-8, PII S0168365997000618
    • J. Kreuter, V.E. Petrov, D.A. Kharkevich, R.N. Alyautdin, Influence of the type of surfactant on the analgesic effects induced by the peptide dalargin after its delivery across the blood-brain barrier using surfactant-coated nanoparticles, J. Control. Release 49 (1997) 81-87. (Pubitemid 27417903)
    • (1997) Journal of Controlled Release , vol.49 , Issue.1 , pp. 81-87
    • Kreuter, J.1    Petrov, V.E.2    Kharkevich, D.A.3    Alyautdin, R.N.4
  • 126
    • 39449117736 scopus 로고    scopus 로고
    • Injectable actarit-loaded solid lipid nanoparticles as passive targeting therapeutic agents for rheumatoid arthritis
    • DOI 10.1016/j.ijpharm.2007.10.014, PII S0378517307008435
    • J. Ye, Q. Wang, X. Zhou, N. Zhang, Injectable actarit-loaded solid lipid nanoparticles as passive targeting therapeutic agents for rheumatoid arthritis, Int. J. Pharm. 352 (2008) 273-279. (Pubitemid 351273921)
    • (2008) International Journal of Pharmaceutics , vol.352 , Issue.1-2 , pp. 273-279
    • Ye, J.1    Wang, Q.2    Zhou, X.3    Zhang, N.4
  • 127
    • 14644396096 scopus 로고    scopus 로고
    • Nanomedicine: Current status and future prospects
    • DOI 10.1096/fj.04-2747rev
    • S.M. Moghimi, A.C. Hunter, J.C. Murray, Nanomedicine: current status and future prospects, FASEB J. 19 (2005) 311-330. (Pubitemid 40316520)
    • (2005) FASEB Journal , vol.19 , Issue.3 , pp. 311-330
    • Moghimi, S.M.1    Hunter, A.C.2    Murray, J.C.3
  • 128
    • 76749169348 scopus 로고    scopus 로고
    • To PEGylate or not PEGylate, that is not the question
    • K. Park, To PEGylate or not PEGylate, that is not the question, J. Control. Release 142 (2010) 147-148.
    • (2010) J. Control. Release , vol.142 , pp. 147-148
    • Park, K.1
  • 130
    • 29244441966 scopus 로고    scopus 로고
    • Poly(ethylene oxide)-modified poly(β-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs: Part 2. In vivo distribution and tumor localization studies
    • DOI 10.1007/s11095-005-8343-0
    • D. Shenoy, S. Little, R. Langer, M. Amiji, Poly(ethylene oxide)-modified poly(- beta-amino ester) nanoparticles as a pH-sensitive system for tumor targeted delivery of hydrophobic drugs: part 2. In vivo distribution and tumor localization studies, Pharm. Res. 22 (2005) 2107-2114. (Pubitemid 41821590)
    • (2005) Pharmaceutical Research , vol.22 , Issue.12 , pp. 2107-2114
    • Shenoy, D.1    Little, S.2    Langer, R.3    Amiji, M.4
  • 131
    • 81755174204 scopus 로고    scopus 로고
    • Surface modified nevirapine nanosuspensions for viral reservoir targeting: In vitro and in vivo evaluation
    • R. Shegokara, K.K. Singha, Surface modified nevirapine nanosuspensions for viral reservoir targeting: in vitro and in vivo evaluation, Int. J. Pharm. 421 (2011) 341-352.
    • (2011) Int. J. Pharm. , vol.421 , pp. 341-352
    • Shegokara, R.1    Singha, K.K.2
  • 132
    • 0022858683 scopus 로고
    • A new concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs
    • Y. Matsumura, H. Maeda, A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent SMANCS, Cancer Res. 46 (1986) 6387-6392. (Pubitemid 17221789)
    • (1986) Cancer Research , vol.46 , Issue.12 I , pp. 6387-6392
    • Matsumura, Y.1    Maeda, H.2
  • 133
    • 79960153105 scopus 로고    scopus 로고
    • Preparation and antitumor study of camptothecin nanocrystals
    • H. Zhang, C.P. Hollis, Q. Zhang, T. Li, Preparation and antitumor study of camptothecin nanocrystals, Int. J. Pharm. 415 (2011) 293-300.
    • (2011) Int. J. Pharm. , vol.415 , pp. 293-300
    • Zhang, H.1    Hollis, C.P.2    Zhang, Q.3    Li, T.4
  • 135
    • 24144452456 scopus 로고    scopus 로고
    • Adsorption kinetics of plasma proteins on solid lipid nanoparticles for drug targeting
    • DOI 10.1016/j.ijpharm.2005.06.025, PII S0378517305004540
    • T.M. Goppert, R.H. Müller, Adsorption kinetics of plasma proteins on solid lipid nanoparticles for drug targeting, Int. J. Pharm. 302 (2005) 172-186. (Pubitemid 41242762)
    • (2005) International Journal of Pharmaceutics , vol.302 , Issue.1-2 , pp. 172-186
    • Goppert, T.M.1    Muller, R.H.2
  • 136
    • 70350782346 scopus 로고    scopus 로고
    • Formulation of nanosuspensions as a new approach for the delivery of poorly soluble drugs
    • X. Pu, J. Sun, M. Li, Z. He, Formulation of nanosuspensions as a new approach for the delivery of poorly soluble drugs, Curr. Nanosci. 5 (2009) 417-427.
    • (2009) Curr. Nanosci. , vol.5 , pp. 417-427
    • Pu, X.1    Sun, J.2    Li, M.3    He, Z.4
  • 138
    • 0032848664 scopus 로고    scopus 로고
    • Targeted delivery of anti-angiogenic agent TNP-470 using water-soluble polymer in the treatment of choroidal neovascularization
    • T. Yasukawa, H. Kimura, Y. Tabata, H. Miyamoto, Y. Honda, Y. Ikada, Y. Ogura, Targeted delivery of anti-angiogenic agent TNP-470 using water-soluble polymer in the treatment of choroidal neovascularization, Invest. Ophthalmol. Vis. Sci. 40 (1999) 2690-2696. (Pubitemid 29455501)
    • (1999) Investigative Ophthalmology and Visual Science , vol.40 , Issue.11 , pp. 2690-2696
    • Yasukawa, T.1    Kimura, H.2    Tabata, Y.3    Miyamoto, H.4    Honda, Y.5    Ikada, Y.6    Ogura, Y.7
  • 139
    • 77955274105 scopus 로고    scopus 로고
    • Delivery of amphotericin B nanosuspensions to the brain and determination of activity against Balamuthia mandrillaris amebas
    • A. Lemke, A.F. Kiderlen, B. Petri, O. Kayser, Delivery of amphotericin B nanosuspensions to the brain and determination of activity against Balamuthia mandrillaris amebas, Nanomedicine 6 (2010) 597-603.
    • (2010) Nanomedicine , vol.6 , pp. 597-603
    • Lemke, A.1    Kiderlen, A.F.2    Petri, B.3    Kayser, O.4
  • 140
    • 84859958800 scopus 로고    scopus 로고
    • Nanotechnological advances for the delivery of CNS therapeutics
    • doi:10.1016/j.addr.2011.10.007
    • H.L. Wong, X.Y. Wu, R. Bendayan, Nanotechnological advances for the delivery of CNS therapeutics, Adv. Drug Deliv. Rev. (2011), doi:10.1016/j.addr. 2011.10.007.
    • (2011) Adv. Drug Deliv. Rev.
    • Wong, H.L.1    Wu, X.Y.2    Bendayan, R.3
  • 141
    • 45249092544 scopus 로고    scopus 로고
    • Use of nanoparticles for cerebral cancer
    • J. Kreuter, S. Gelperina, Use of nanoparticles for cerebral cancer, Tumori 94 (2008) 271-277. (Pubitemid 351838835)
    • (2008) Tumori , vol.94 , Issue.2 , pp. 271-277
    • Kreuter, J.1    Gelperina, S.2
  • 142
    • 0028911362 scopus 로고
    • Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles)
    • J. Kreuter, R.N. Alyautdin, D.A. Kharkevich, A.A. Ivanov, Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles), Brain Res. 674 (1995) 171-174.
    • (1995) Brain Res. , vol.674 , pp. 171-174
    • Kreuter, J.1    Alyautdin, R.N.2    Kharkevich, D.A.3    Ivanov, A.A.4
  • 143
    • 0035937595 scopus 로고    scopus 로고
    • Nanoparticulate systems for brain delivery of drugs
    • DOI 10.1016/S0169-409X(00)00122-8, PII S0169409X00001228
    • J. Kreuter, Nanoparticulate systems for brain delivery of drugs, Adv. Drug Deliv. Rev. 47 (2001) 65-81. (Pubitemid 32209233)
    • (2001) Advanced Drug Delivery Reviews , vol.47 , Issue.1 , pp. 65-81
    • Kreuter, J.1
  • 144
    • 18744413936 scopus 로고    scopus 로고
    • Polysorbate-stabilized solid lipid nanoparticles as colloidal carriers for intravenous targeting of drugs to the brain: Comparison of plasma protein adsorption patterns
    • T.M. Göppert, R.H. Müller, Polysorbate-stabilized solid lipid nanoparticles as colloidal carriers for intravenous targeting of drugs to the brain: comparison of plasma protein adsorption patterns, J. Drug Target. 13 (2005) 179-187.
    • (2005) J. Drug Target. , vol.13 , pp. 179-187
    • Göppert, T.M.1    Müller, R.H.2
  • 145
    • 28744456012 scopus 로고    scopus 로고
    • Characterization of folate-chitosan-DNA nanoparticles for gene therapy
    • DOI 10.1016/j.biomaterials.2005.09.020, PII S0142961205008628
    • S. Mansouri, Y. Cuie, F. Winnik, Q. Shi, P. Lavigne, M. Benderdour, E. Beaumont, J.C. Fernandes, Characterization of folate-chitosan-DNA nanoparticles for gene therapy, Biomaterials 27 (2006) 2060-2065. (Pubitemid 41759500)
    • (2006) Biomaterials , vol.27 , Issue.9 , pp. 2060-2065
    • Mansouri, S.1    Cuie, Y.2    Winnik, F.3    Shi, Q.4    Lavigne, P.5    Benderdour, M.6    Beaumont, E.7    Fernandes, J.C.8
  • 146
    • 27944455140 scopus 로고    scopus 로고
    • Folate receptor-mediated drug targeting: From therapeutics to diagnostics
    • DOI 10.1002/jps.20457
    • A.R. Hilgenbrink, P.S. Low, Folate receptor-mediated drug targeting: from therapeutics to diagnostics, J. Pharm. Sci. 94 (2005) 2135-2146. (Pubitemid 41665275)
    • (2005) Journal of Pharmaceutical Sciences , vol.94 , Issue.10 , pp. 2135-2146
    • Hilgenbrink, A.R.1    Low, P.S.2
  • 147
    • 36849065709 scopus 로고    scopus 로고
    • Cell-based drug delivery
    • DOI 10.1016/j.addr.2007.08.029, PII S0169409X07002505, Emerging Trends in Cell-Based Therapies
    • F. Pierigè, S. Serafini, L. Rossi, M. Magnani, Cell-based drug delivery, Adv. Drug Deliv. Rev. 60 (2008) 286-295. (Pubitemid 350236405)
    • (2008) Advanced Drug Delivery Reviews , vol.60 , Issue.2 , pp. 286-295
    • Pierige, F.1    Serafini, S.2    Rossi, L.3    Magnani, M.4
  • 148
    • 23644437163 scopus 로고    scopus 로고
    • Therapeutic potential of nanoparticulate systems for macrophage targeting
    • DOI 10.1016/j.biomaterials.2005.05.044, PII S0142961205004497, Canadian Biomaterials Research
    • F. Chellat, Y. Merhi, A. Moreau, L. Yahia, Therapeutic potential of nanoparticulate systems for macrophage targeting, Biomaterials 26 (2005) 7260-7275. (Pubitemid 41133578)
    • (2005) Biomaterials , vol.26 , Issue.35 , pp. 7260-7275
    • Chellat, F.1    Merhi, Y.2    Moreau, A.3    Yahia, L.4
  • 149
    • 34250325127 scopus 로고    scopus 로고
    • Identification of peptide ligands facilitating nanoparticle attachment to erythrocytes
    • DOI 10.1021/bp060333l
    • S.S. Hall, S. Mitragotri, P.S. Daugherty, Identification of peptide ligands facilitating nanoparticle at attachment to erythrocytes, Biotechnol. Prog. 23 (2007) 749-754. (Pubitemid 46911204)
    • (2007) Biotechnology Progress , vol.23 , Issue.3 , pp. 749-754
    • Hall, S.S.1    Mitragotri, S.2    Daugherty, P.S.3
  • 151
    • 0037451745 scopus 로고    scopus 로고
    • Delivery to macrophages and toxic action of etoposide carried in mouse red blood cells
    • DOI 10.1016/S0304-4165(02)00536-6
    • L.A. Lotero, G. Olmos, J.C. Diez, Delivery to macrophages and toxic action of etoposide carried inmouse red blood cells, Biochim. Biophys. Acta 1620 (2003) 160-166. (Pubitemid 36197907)
    • (2003) Biochimica et Biophysica Acta - General Subjects , vol.1620 , Issue.1-3 , pp. 160-166
    • Lotero, L.A.1    Olmos, G.2    Diez, J.C.3
  • 155
    • 73949146977 scopus 로고    scopus 로고
    • In vitro inhibition of fungal activity by macrophage-mediated sequestration and release of encapsulated amphotericin B nanosuspension in red blood cells
    • V. Staedtke, M. Bräler, A. Müller, R. Georgieva, S. Bauer, N. Sternberg, A. Voigt, A. Lemke, C. Keck, J. Möschwitzer, H. Bäumler, In vitro inhibition of fungal activity by macrophage-mediated sequestration and release of encapsulated amphotericin B nanosuspension in red blood cells, Small 6 (2010) 96-103.
    • (2010) Small , vol.6 , pp. 96-103
    • Staedtke, V.1    Bräler, M.2    Müller, A.3    Georgieva, R.4    Bauer, S.5    Sternberg6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.